Page last updated: 2024-10-26

racemetirosine and Bulimia

racemetirosine has been researched along with Bulimia in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Homan, P1
Grob, S1
Milos, G1
Schnyder, U1
Hasler, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Neuronal Correlates of Catecholamine Depletion in Patients With Bulimia Nervosa Off Medication and Healthy Controls[NCT02179814]60 participants (Anticipated)Interventional2012-02-20Suspended (stopped due to Conduct of the first analyses)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for racemetirosine and Bulimia

ArticleYear
Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptoms.
    Psychoneuroendocrinology, 2013, Volume: 38, Issue:9

    Topics: Adult; alpha-Methyltyrosine; Body Mass Index; Bulimia; Catecholamines; Convalescence; Cross-Over Stu

2013